Clinical trial
Radiation Therapy With Capecitabine in Rectal Cancer
NCT00176787 · University of Michigan Rogel Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00176787 |
|---|---|
| Title | Radiation Therapy With Capecitabine in Rectal Cancer |
| Official title | Phase II Trial of Preoperative Radiation Therapy With Capecitabine in Rectal Cancer (UMCC 0046) |
| Lead sponsor | University of Michigan Rogel Cancer Center, Other |
| Collaborators | Hoffmann-La Roche Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rectal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Capecitabine, Radiation, Surgery |
| Enrollment | 30 |
| Start date | Oct 1, 2000 |
| Primary completion | May 1, 2005 |
| Completion | Jun 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 10, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: